S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.03 (-1.78%)
MU   50.58 (-3.42%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.03 (-1.78%)
MU   50.58 (-3.42%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.03 (-1.78%)
MU   50.58 (-3.42%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.03 (-1.78%)
MU   50.58 (-3.42%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
Log in

NASDAQ:TRNS - Transcat Stock Price, Forecast & News

$28.72
-2.00 (-6.51 %)
(As of 02/27/2020 04:00 PM ET)
Today's Range
$27.83
Now: $28.72
$31.41
50-Day Range
$28.72
MA: $31.58
$32.90
52-Week Range
$20.66
Now: $28.72
$34.18
Volume53,760 shs
Average Volume19,332 shs
Market Capitalization$211.95 million
P/E Ratio26.11
Dividend YieldN/A
Beta0.8
Transcat, Inc provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management software that is used to integrate and manage the workflow of its calibration service centers and customers' assets; CalTrak Online, which provides its customers with Web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records; and Compliance, Control and Cost, a cloud-based customer portal and asset management tool. Read More…

Industry, Sector and Symbol

Industry Instruments to measure electricity
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:TRNS
CUSIPN/A
Phone585-352-7777

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$160.90 million
Cash Flow$1.78 per share
Book Value$8.78 per share

Profitability

Net Income$7.14 million

Miscellaneous

Employees571
Market Cap$211.95 million
Next Earnings Date5/19/2020 (Estimated)
OptionableNot Optionable

Receive TRNS News and Ratings via Email

Sign-up to receive the latest news and ratings for TRNS and its competitors with MarketBeat's FREE daily newsletter.


Transcat (NASDAQ:TRNS) Frequently Asked Questions

What is Transcat's stock symbol?

Transcat trades on the NASDAQ under the ticker symbol "TRNS."

How were Transcat's earnings last quarter?

Transcat, Inc. (NASDAQ:TRNS) announced its earnings results on Tuesday, February, 4th. The scientific and technical instruments company reported $0.20 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.25 by $0.05. The scientific and technical instruments company earned $43.18 million during the quarter, compared to the consensus estimate of $42.10 million. Transcat had a net margin of 4.79% and a return on equity of 13.29%. View Transcat's Earnings History.

When is Transcat's next earnings date?

Transcat is scheduled to release their next quarterly earnings announcement on Tuesday, May 19th 2020. View Earnings Estimates for Transcat.

What price target have analysts set for TRNS?

3 brokerages have issued 12-month price targets for Transcat's stock. Their forecasts range from $34.50 to $42.00. On average, they expect Transcat's share price to reach $37.17 in the next twelve months. This suggests a possible upside of 29.4% from the stock's current price. View Analyst Price Targets for Transcat.

What is the consensus analysts' recommendation for Transcat?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Transcat in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Transcat.

Has Transcat been receiving favorable news coverage?

Headlines about TRNS stock have trended extremely negative this week, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Transcat earned a coverage optimism score of -4.2 on InfoTrie's scale. They also gave news headlines about the scientific and technical instruments company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Transcat.

Are investors shorting Transcat?

Transcat saw a drop in short interest in February. As of February 14th, there was short interest totalling 57,400 shares, a drop of 10.2% from the January 30th total of 63,900 shares. Based on an average daily volume of 19,800 shares, the days-to-cover ratio is currently 2.9 days. Currently, 0.8% of the company's shares are sold short. View Transcat's Current Options Chain.

Who are some of Transcat's key competitors?

What other stocks do shareholders of Transcat own?

Who are Transcat's key executives?

Transcat's management team includes the folowing people:
  • Mr. Lee D. Rudow, Pres, CEO & Director (Age 55)
  • Mr. Michael J Tschiderer, VP of Fin., CFO, Treasurer & Corp. Sec. (Age 59)
  • Mr. Robert A. Flack, VP of Service Sales & Operations (Age 49)
  • Mr. Scott D. Deverell, Corp. Controller & Principal Accounting Officer (Age 53)
  • Mr. Michael W. West, VP of Inside Sales & Marketing (Age 48)

Who are Transcat's major shareholders?

Transcat's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include ACK Asset Management LLC (5.71%), Minerva Advisors LLC (4.56%), Punch & Associates Investment Management Inc. (3.49%), THB Asset Management (2.84%), Dalton Greiner Hartman Maher & Co. (2.46%) and ArrowMark Colorado Holdings LLC (2.22%). Company insiders that own Transcat stock include Alan H Resnick, Carl E Sassano, Charles P Hadeed, Gary J Haseley, John T Smith, Michael Tschiderer, Richard J Harrison, Robert A Flack and Scott Deverell. View Institutional Ownership Trends for Transcat.

Which institutional investors are selling Transcat stock?

TRNS stock was sold by a variety of institutional investors in the last quarter, including Punch & Associates Investment Management Inc., Minerva Advisors LLC, Dalton Greiner Hartman Maher & Co., Manatuck Hill Partners LLC, Renaissance Technologies LLC, ACK Asset Management LLC, Wedge Capital Management L L P NC and Perritt Capital Management Inc.. Company insiders that have sold Transcat company stock in the last year include Carl E Sassano, Charles P Hadeed, John T Smith, Richard J Harrison, Robert A Flack and Scott Deverell. View Insider Buying and Selling for Transcat.

Which institutional investors are buying Transcat stock?

TRNS stock was bought by a variety of institutional investors in the last quarter, including ArrowMark Colorado Holdings LLC, EAM Global Investors LLC, EAM Investors LLC, State Street Corp, Goldman Sachs Group Inc., Royce & Associates LP, Geode Capital Management LLC and Russell Investments Group Ltd.. Company insiders that have bought Transcat stock in the last two years include Gary J Haseley and Michael Tschiderer. View Insider Buying and Selling for Transcat.

How do I buy shares of Transcat?

Shares of TRNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Transcat's stock price today?

One share of TRNS stock can currently be purchased for approximately $28.72.

How big of a company is Transcat?

Transcat has a market capitalization of $211.95 million and generates $160.90 million in revenue each year. The scientific and technical instruments company earns $7.14 million in net income (profit) each year or $0.95 on an earnings per share basis. Transcat employs 571 workers across the globe.View Additional Information About Transcat.

What is Transcat's official website?

The official website for Transcat is http://www.transcat.com/.

How can I contact Transcat?

Transcat's mailing address is 35 VANTAGE POINT DRIVE, ROCHESTER NY, 14624. The scientific and technical instruments company can be reached via phone at 585-352-7777 or via email at [email protected]


MarketBeat Community Rating for Transcat (NASDAQ TRNS)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  156 (Vote Outperform)
Underperform Votes:  131 (Vote Underperform)
Total Votes:  287
MarketBeat's community ratings are surveys of what our community members think about Transcat and other stocks. Vote "Outperform" if you believe TRNS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRNS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel